Injury Prevention Among Conscripts (VASTE)

January 4, 2008 updated by: UKK Institute

Prevention of Musculoskeletal Injuries in Finnish Conscripts. A Cluster Randomized Controlled Trial.

The purpose of this clinical trial is to study the effect of neuromuscular training program and regular safety counselling on the risk of musculoskeletal injuries in adolescent conscripts.

800 voluntary participants are recruited from the four army companies in western Finland during the years 2007 and 2008.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

800

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Finland
      • Tampere, Finland, 33500
        • Jari Parkkari
    • P.O Box 30
      • Tampere, P.O Box 30, Finland, 33501
        • Jari Parkkari

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 26 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • healthy conscripts who gave informed consent for participation

Exclusion Criteria:

  • disease or injury preventing physical training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
Active treatment: physical training and counselling
Other: physical training and counselling
Neuromuscular training program 3 times per week 30 minutes per session and counselling on back problems and other musculosceletal injuries

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Musculoskeletal injuries
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Intensity of low back pain, Physical fitness
Time Frame: 1,2,6 months
1,2,6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

UKK Institute

Collaborators

Finland's Slot Machine Association (RAY)
Ministry of Education
Scientific Advisory Board for Defence (MATINE)

Investigators

  • Principal Investigator: Jari P Parkkari, MD, PhD, The UKK Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2007

Primary Completion (Actual)

January 1, 2008

Study Completion (Actual)

January 1, 2008

Study Registration Dates

First Submitted

January 4, 2008

First Submitted That Met QC Criteria

January 4, 2008

First Posted (Estimate)

January 16, 2008

Study Record Updates

Last Update Posted (Estimate)

January 16, 2008

Last Update Submitted That Met QC Criteria

January 4, 2008

Last Verified

January 1, 2008

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UKK VASTE

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe